ArticleCell death & disease2021

NDUFA4L2 promotes glioblastoma progression, is associated with poor survival, and can be effectively targeted by apatinib.

Zheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.